Applied Materials vs. Intel: Which Tech Stock Is a Better Buy in 2026?

Applied Materials is presented as the more attractive 2026 investment, supported by FY2025 revenue of $28.4B (+4.4%), $7.0B of net income, and $5.7B of free cash flow, versus Intel's $52.9B of flat revenue, $267M net loss, and negative $4.9B free cash flow. Intel's foundry transformation offers strategic upside but requires substantial capital spending, follows an $18.8B FY2024 loss, and carries dilution, execution, and litigation risks. Applied Materials also trades at a lower forward P/E of 33.4x versus Intel's 59.2x, though it faces China export-control risk after a $252M February 2026 settlement.

Analysis

The relevant distinction is not toolmaker versus foundry, but earnings conversion versus execution duration. AMAT monetizes broadly distributed leading-edge process complexity with modest incremental capital needs, whereas INTC must fund capacity years before utilization, yields, and external-customer mix can validate returns. That makes AMAT’s near-term multiple vulnerable to any wafer-fab-equipment order pause, but its free-cash-flow durability supports faster downside recovery than Intel if AI-related capex normalizes.

Intel’s foundry economics remain a utilization problem disguised as a technology roadmap. A single disclosed leading-edge customer does not establish a commercial pipeline sufficient to absorb fixed fab depreciation; until meaningful third-party wafer commitments are disclosed, each additional capex dollar raises the risk of lower returns, dilution, or government-supported economics that do not accrue proportionately to common equity. AMD is a secondary beneficiary if Intel’s internal-product execution remains uneven, as server buyers continue to seek an alternative to Intel platforms, while TSMC remains the more direct beneficiary of foundry share uncertainty.

Over the next 1-3 months, export-control enforcement is a more asymmetric risk for AMAT than the settlement amount itself: tighter rules could force China revenue and service-part utilization lower, pressuring both sales and gross mix. Conversely, a resilient China order book and sustained advanced-packaging demand would support estimates. Over 6-18 months, AMAT wins if leading-edge logic, memory recovery, and packaging intensity offset China restrictions; INTC needs externally verifiable customer commitments, improving foundry gross margin, and materially narrower free-cash-flow burn to rerate.

Consensus may be too quick to treat INTC’s low price-to-sales ratio as value. Sales do not capture the capital intensity, depreciation burden, and ownership dilution embedded in the foundry transition. AMAT is the higher-quality asset but is not automatically cheap at its earnings multiple; the cleaner trade is relative exposure rather than unhedged AMAT beta.

Key Decisions for Investors

• Initiate a 6-12 month long AMAT / short INTC dollar-neutral pair. Target relative outperformance of 15-20%; exit if Intel discloses multiple binding external foundry customers with volume/take-or-pay terms or if AMAT guides China-related revenue down materially.
• Use AMAT earnings as the entry gate rather than chase ahead of results: add only if orders and service outlook confirm that China restrictions are being offset by advanced-node and packaging demand. A 10%+ cut to forward EPS or a clear order-decline guide invalidates the long leg.
• Maintain AMD as a tactical 3-6 month beneficiary of Intel execution risk, but do not use it as a pure foundry proxy; AMD valuation sensitivity to AI accelerator demand can dominate CPU-share gains. Prefer AMD funded against INTC only after evidence of further Intel server-platform delays or weak enterprise demand.
• Set an alert for Intel quarterly foundry gross margin, capex, and free-cash-flow trajectory. No new directional INTC long is warranted until foundry losses narrow while capex falls or external-customer backlog becomes quantifiable; absent that evidence, the apparent sales multiple discount is likely a value trap.